XAGE

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: SRDX MDXG AXGN RCEL OSUR VERO PAVM HSDT SENS

Index	-	P/E	-	EPS (ttm)	-8.38	Insider Own	10.70%	Shs Outstand	1.78M	Perf Week	-20.99%
Market Cap	3.42M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.62M	Perf Month	-20.00%
Enterprise Value	2.24M	PEG	-	EPS next Q	-	Inst Own	1.76%	Short Float	0.55%	Perf Quarter	-27.27%
Income	-7.09M	P/S	3.26	EPS this Y	-	Inst Trans	0.69%	Short Ratio	0.00	Perf Half Y	-75.00%
Sales	1.05M	P/B	-	EPS next Y	-	ROA	-164.17%	Short Interest	0.01M	Perf YTD	-77.07%
Book/sh	-2.52	P/C	2.21	EPS next 5Y	-	ROE	-	52W High	38.10 -94.96%	Perf Year	-86.38%
Cash/sh	0.87	P/FCF	-	EPS past 3/5Y	-270.08% -	ROIC	-	52W Low	2.15 -10.70%	Perf 3Y	-99.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	36.47%	Volatility	20.02% 11.35%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.13	EPS Y/Y TTM	50.20%	Oper. Margin	-550.59%	ATR (14)	0.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.29	Sales Y/Y TTM	-	Profit Margin	-673.51%	RSI (14)	34.67	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.46	EPS Q/Q	67.39%	SMA20	-24.08%	Beta	0.50	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	3987.76%	SMA50	-34.87%	Rel Volume	0.06	Prev Close	2.32
Employees	15	LT Debt/Eq	-	Earnings	-	SMA200	-67.22%	Avg Volume	1.79M	Price	1.92
IPO	Sep 23, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	107,395	Change	-17.24%

Jul-14-25 04:30PM	Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction (GlobeNewswire) +115.50%
May-28-25 09:25AM	Longevity Health extends cash runway into 1Q26 (TipRanks) +12.55%
May-27-25 09:20AM	Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale (GlobeNewswire) +10.50%
May-21-25 04:30PM	Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs (GlobeNewswire) -6.13% +12.75%
May-15-25 08:04AM	Longevity Health Holdings Announces Business Updates (GlobeNewswire) +10.18%
08:00AM	Loading…
May-12-25 08:00AM	Longevity Health Holdings, Inc. Announces Reverse Stock Split (GlobeNewswire) -16.99%
Apr-14-25 08:03AM	Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs (GlobeNewswire) +63.72%
Jan-16-25 08:00AM	Carmell Announces Closing of Elevai Skincare Acquisition (GlobeNewswire) +8.18%
Jan-03-25 08:00AM	Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out (GlobeNewswire) -10.85%
Jan-02-25 08:00AM	Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products (GlobeNewswire) +147.98%
Dec-24-24 08:30AM	Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out (GlobeNewswire) +26.20%
Sep-05-24 08:30AM	Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community (GlobeNewswire) -11.29%
Jul-29-24 08:30AM	Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index (GlobeNewswire) +13.00%
May-16-24 08:54AM	CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 04:30PM	Carmell Announces Successful Closing of $3.0 Million Private Placement (GlobeNewswire) -5.60%
08:30AM	Loading…
Apr-04-24 08:30AM	Carmell Announces $3.0 Million Private Placement (GlobeNewswire) -9.72%
Mar-27-24 09:15AM	Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction (GlobeNewswire) -11.03%
Mar-20-24 04:39PM	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary (GlobeNewswire) +11.84% +5.84%
Mar-18-24 03:16PM	Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field (GlobeNewswire)
Feb-26-24 08:30AM	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 (GlobeNewswire) +28.92%
Nov-16-23 08:30AM	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors (GlobeNewswire)
Sep-12-23 12:35PM	Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine (PR Newswire)
Sep-05-23 06:03PM	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics (GlobeNewswire) +17.60%
Aug-09-23 03:41PM	Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity (Business Wire)
Jul-27-23 07:00AM	Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (Business Wire) +46.00%

Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its cosmetic product lines include Carmell Secretome and Elevai Exosomes, that support skin and hair health. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Longevity Health Holdings Inc

Upgrade your FINVIZ experience